National and Kapodistrian University of Athens
Προκλινική δοκιμασία θεραπευτικής αναστολής των χημειοκινών MCP-1/5 σε πρότυπο κακοήθους υπεζωκοτικής συλλογής ποντικών
Abstract
dc:descriptionUsing genetic interventions, we previously determined that C-C motif chemokine ligand 2(CCL2) promotes malignant pleural effusion (MPE) formation in mice. Here we conductedpreclinical studies aimed at assessing the specific therapeutic potential of antibody-mediatedCCL2 blockade against MPE. For this, murine MPEs or skin tumors were generated inC57BL/6 mice by intrapleural or subcutaneous delivery of lung (LLC) or colon (MC38)adenocarcinoma cells. Human lung adenocarcinoma cells (A549) were used to induce MPEsin severe combined immunodeficient mice. Intraperitoneal antibodies neutralizing mouseCCL2 and/or CCL12, a murine CCL2 ortholog, were administered at 10 or 50 mg/kg everythree days. We found that high doses of CCL2/12 neutralizing antibody treatment (50 mg/kg)were required to limit MPE formation by LLC cells. CCL2 and CCL12 blockade were equallypotent inhibitors of MPE development by LLC cells. Combined CCL2 and CCL12neutralization was also effective against MC38-induced MPE and prolonged the survival ofmice in both syngeneic models. Mouse-specific CCL2-blockade limited A549-causedxenogeneic MPE, indicating that host - derived CCL2 also contributes to MPE precipitationin mice. The impact of CCL2/12 antagonism was associated with inhibition of immune andvascular MPE-related phenomena, such as inflammation, new blood vessel assembly andplasma extravasation into the pleural space. We conclude that CCL2 and CCL12 blockade areeffective against experimental MPE induced by murine and human adenocarcinoma in mice.These results suggest that CCL2-targeted therapies may hold promise for future use against human MPE.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2014
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kairi, Chrisoula
- Καΐρη, Χρυσούλα
Subjects
dc:subject × 15Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/40435